Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Supernus Pharm (SUPN)

Supernus Pharm (SUPN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,589,065
  • Shares Outstanding, K 53,146
  • Annual Sales, $ 520,400 K
  • Annual Income, $ 126,950 K
  • 60-Month Beta 1.23
  • Price/Sales 3.03
  • Price/Cash Flow 9.84
  • Price/Book 2.00
Trade SUPN with:

Options Overview Details

View History
  • Implied Volatility 64.82%
  • Historical Volatility 44.33%
  • IV Percentile 58%
  • IV Rank 47.65%
  • IV High 99.34% on 10/22/20
  • IV Low 33.40% on 09/23/21
  • Put/Call Vol Ratio 0.24
  • Today's Volume 120
  • Volume Avg (30-Day) 144
  • Put/Call OI Ratio 5.15
  • Today's Open Interest 166
  • Open Int (30-Day) 1,492

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate 0.21
  • Number of Estimates 3
  • High Estimate 0.26
  • Low Estimate 0.18
  • Prior Year 0.74
  • Growth Rate Est. (year over year) -71.62%

Price Performance

See More
Period Period Low Period High Performance
1-Month
26.13 +12.44%
on 10/06/21
32.32 -9.10%
on 10/15/21
+2.12 (+7.78%)
since 09/21/21
3-Month
23.15 +26.91%
on 08/20/21
32.32 -9.10%
on 10/15/21
+1.68 (+6.06%)
since 07/21/21
52-Week
17.20 +70.81%
on 10/29/20
34.29 -14.32%
on 06/16/21
+9.63 (+48.76%)
since 10/21/20

Most Recent Stories

More News
Supernus Pharmaceuticals to Acquire Adamas Pharmaceuticals Strengthening its CNS Product Portfolio

Acquisition of two marketed products diversifies and accelerates revenue and cash flowExpected to be significantly accretive in 2022Potential synergies of...

SUPN : 29.38 (-1.74%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. It is developing several product candidates in neurology and psychiatry to address opportunities in epilepsy and attention deficit...

See More

Key Turning Points

3rd Resistance Point 30.86
2nd Resistance Point 30.49
1st Resistance Point 29.93
Last Price 29.38
1st Support Level 29.01
2nd Support Level 28.64
3rd Support Level 28.09

See More

52-Week High 34.29
Last Price 29.38
Fibonacci 61.8% 27.76
Fibonacci 50% 25.75
Fibonacci 38.2% 23.73
52-Week Low 17.20

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar